Literature DB >> 10052984

Effects of additives on the stability of Humicola lanuginosa lipase during freeze-drying and storage in the dried solid.

L Kreilgaard1, S Frokjaer, J M Flink, T W Randolph, J F Carpenter.   

Abstract

The effects of various classes of additives on the stability of a protein with a relatively hydrophobic surface, Humicola lanuginosa lipase (HLL), during lyophilization and storage in the dried solid, were investigated. Prior to lyophilization, it was found that 1 M trehalose or 1% (wt/vol) Tween 20 caused the protein to precipitate. Infrared spectroscopy indicated that trehalose "salted-out" native HLL, whereas Tween 20 induced non-native aggregates. Optimal recovery of native protein in the initial dried solid was obtained in the presence of additives which formed an amorphous phase and which had the capacity to hydrogen bond to the dried protein (e.g., trehalose and sucrose). Additives which crystallized during lyophilization (e.g., mannitol) or which remained amorphous, but were unable to hydrogen bond to the dried protein (e.g., dextran), afforded less stabilization relative to that seen in the absence of additives. Optimal storage stability in the dried solid required that both protein unfolding during lyophilization was minimized and that the formulation was stored at a temperature below its Tg value. Crystallization of sucrose during storage greatly reduced the storage stability of HLL. This was attributed to the increased moisture content and the reduced Tg value in the remaining amorphous phase containing the protein. Sucrose crystallization and the resulting damage to the protein were inhibited by decreasing the mass ratio of sucrose:protein.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10052984     DOI: 10.1021/js980399d

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

1.  Effect of moisture on the stability of a lyophilized humanized monoclonal antibody formulation.

Authors:  E D Breen; J G Curley; D E Overcashier; C C Hsu; S J Shire
Journal:  Pharm Res       Date:  2001-09       Impact factor: 4.200

2.  Effects of Excipient Interactions on the State of the Freeze-Concentrate and Protein Stability.

Authors:  Sampreeti Jena; Jacqueline Horn; Raj Suryanarayanan; Wolfgang Friess; Alptekin Aksan
Journal:  Pharm Res       Date:  2016-12-15       Impact factor: 4.200

3.  Formulation for a novel inhaled peptide therapeutic for idiopathic pulmonary fibrosis.

Authors:  Soraya Hengsawas Surasarang; Galina Florova; Andrey A Komissarov; Sreerama Shetty; Steven Idell; Robert O Williams
Journal:  Drug Dev Ind Pharm       Date:  2017-11-10       Impact factor: 3.225

4.  Freeze-concentration separates proteins and polymer excipients into different amorphous phases.

Authors:  K Izutsu; S Kojima
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

5.  Implications of global and local mobility in amorphous sucrose and trehalose as determined by differential scanning calorimetry.

Authors:  Ion Dranca; Sisir Bhattacharya; Sergey Vyazovkin; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2009-01-09       Impact factor: 4.200

Review 6.  Microcalorimetry: a response to challenges in modern biotechnology.

Authors:  Tino Krell
Journal:  Microb Biotechnol       Date:  2008-03       Impact factor: 5.813

7.  Biophysical evaluation of aminoclay as an effective protectant for protein stabilization during freeze-drying and storage.

Authors:  Jae Geun Song; Sang Hoon Lee; Hyo-Kyung Han
Journal:  Int J Nanomedicine       Date:  2016-12-12

8.  Towards water-free biobanks: long-term dry-preservation at room temperature of desiccation-sensitive enzyme luciferase in air-dried insect cells.

Authors:  Shingo Kikuta; Shunsuke J Watanabe; Ryoichi Sato; Oleg Gusev; Alexander Nesmelov; Yoichiro Sogame; Richard Cornette; Takahiro Kikawada
Journal:  Sci Rep       Date:  2017-07-26       Impact factor: 4.379

9.  Dextranol: An inert xeroprotectant.

Authors:  Bryan J Jones; Advitiya Mahajan; Alptekin Aksan
Journal:  PLoS One       Date:  2019-09-06       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.